A phase I clinical trial assessing prophylactic infusion of donor CD45RA-negative memory - effector T cells into patients transplanted with hematopoietic stem cells from haploidentical donors after reduced intensity conditioning
This “allocated fund” from the Symphasis charitable umbrella foundation was awarded to Dr. Anne-Claire Mamez from the Geneva University Hospitals in April 2018.